electroCore to Announce Fourth Quarter and Year Ended December 31, 2021 Financial Results on Thursday, March 10

Rhea-AI Summary

electroCore, Inc. (Nasdaq: ECOR) will report its financial results for Q4 and the year ending December 31, 2021, on March 10, 2022. A conference call will follow at 4:30 PM EST to discuss results and answer questions. The company's focus is on non-invasive vagus nerve stimulation therapy for treating conditions like migraines and cluster headaches.

Positive

• Focus on non-invasive treatment options is aligned with growing trends in healthcare.
• Established indications for multiple neurology-related conditions may indicate potential market growth.

Negative

• None.

Conference Call to be Held at 4:30 PM Eastern Standard Time

ROCKAWAY, N.J., March 03, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that it will report financial results for the fourth quarter and year ended December 31, 2021, after the close of the market on Thursday, March 10, 2022. Management will host a conference call and webcast at 4:30 PM Eastern Standard Time to discuss the financial results and answer questions.

Thursday, March 10, 2022, 4:30 PM Eastern Standard Time
Domestic: 877-269-7756
International: 201-689-7817
Conference ID: 13726544
Webcast: electroCore Earnings Webcast

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.

For more information, visit www.electrocore.com. 

Investors:
Rich Cockrell
CG Capital
404-736-3838
ecor@cg.capital
or
Media Contact:
Jackie Dorsky
electroCore
908-313-6331
jackie.dorsky@electrocore.com

FAQ

When will electroCore announce its financial results for Q4 2021?

electroCore will announce its financial results for Q4 2021 on March 10, 2022.

What time is the electroCore conference call scheduled?

The electroCore conference call is scheduled for 4:30 PM Eastern Standard Time on March 10, 2022.

What is the focus of electroCore's business?

electroCore focuses on bioelectronic medicine, particularly non-invasive vagus nerve stimulation therapy for treating neurological conditions.

What conditions does electroCore's therapy target?

The therapy targets conditions including migraines, cluster headaches, and other related neurological issues.